Lipella Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 09:05 pm
Lipella Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 0.106676 million. Net loss was USD 1.54 million compared to USD 0.782024 million a year ago. Basic loss per share from continuing operations was USD 0.27 compared to USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 0.27 compared to USD 0.2 a year ago.
For the six months, revenue was USD 0.224724 million compared to USD 0.033149 million a year ago. Net loss was USD 2.61 million compared to USD 1.52 million a year ago. Basic loss per share from continuing operations was USD 0.45 compared to USD 0.39 a year ago. Diluted loss per share from continuing operations was USD 0.45 compared to USD 0.39 a year ago.